Skip to main content

Table 1 Demographic comparison of HIV-infected subjects who were positive or negative for the HLA-B*57:01 allele

From: HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects

HIV-1-Infected Subjects

Screening Population HLA-B*57:01 Positive (n = 13)

Screening Population HLA-B*57:01 Negative (n = 372)

Total Enrolled Population HLA-B*57:01 Negative (N = 296)

Median Age (range)

42 (26–62)

44 (19–70)

43.5 (20–68)

Male, n (%)

9 (69%)

298 (80%)

234 (79%)

Race

 African-American/African Heritage, n (%)

2 (15%)

132 (35%)

102 (34%)

 White, n (%)

11 (85%)

216 (58%)

177 (60%)

 Asian/Other, n (%)

0

24 (6%)

17 (6%)

Ethnicity

 Hispanic/Latino, n (%)

2 (15%)

88 (24%)

77 (26%)

Median CD4 cells/mm3 (range) based on Day 1 values

321 (129–984)

482 (19–1553)

489.5 (77–1479)a

  1. aThis difference was not statistically significant (P = 0.0695, Wilcoxon rank sum test)